Positron (POSC) Stock Price, News & Analysis

Company Overview

Positron Corporation is a medical device company focused on positron emission tomography (PET), an imaging technology used to evaluate physiological and metabolic activity in the body. The company develops, manufactures and distributes PET imaging systems and related products for the nuclear medicine market.

Its product focus has included dedicated PET systems designed for applications such as cardiac imaging, as well as technologies intended to support the diagnosis and management of cardiovascular disease, cancer and other medical conditions. Positron has also been involved in the development and distribution of radiopharmaceutical products used in PET procedures.

The company’s activities have primarily centered on serving healthcare providers and nuclear medicine markets in North America. Publicly available information about its current operations, geographic reach and leadership is limited.

Key Stats

• Today's Range: $1.67 to $1.75
• 50-Day Range: $1.57 to $1.92
• 52-Week Range: $1.27 to $2.74
• Volume: 11,631 shs
• Average Volume: 22,777 shs
• Market Capitalization: $55.28 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Positron Stock Analysis - MarketRank™

Positron scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Positron.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Positron is -5.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Positron is -5.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Positron has a P/B Ratio of 41.75. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.03% of the float of Positron has been sold short.

Short Interest Ratio / Days to Cover

Positron has a short interest ratio ("days to cover") of 0.17, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Positron has recently increased by 58.40%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Positron does not currently pay a dividend.

Dividend Growth

Positron does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Sentiment

Positron has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Positron this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Positron insiders have not sold or bought any company stock.

Percentage Held by Insiders

17.20% of the stock of Positron is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Positron has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/14/2026
• Today: 10/11/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:POSC
• CIK: 844985
• Web: www.positron.com
• Phone: (317) 576-0183
• Fax: 630-537-1249
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.32)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$10.60 million
• Net Margins: -2,279.55%
• Pretax Margin: -2,269.44%
• Return on Equity: -2,415.88%
• Return on Assets: -328.63%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.49
• Quick Ratio: 0.19

Sales & Book Value

• Annual Sales: $460 thousand
• Price / Sales: 120.17
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.04 per share
• Price / Book: 41.75

Miscellaneous

• Outstanding Shares: 33,100,000
• Free Float: 27,403,000
• Market Cap: $55.28 million
• Optionable: Not Optionable
• Beta: 0.53